Eli Lilly has launched its dispensing and delivery service LillyDirect in the UK, the drugmaker announced today.
It said LillyDirect is currently available for private prescriptions of its blockbuster weight loss medicine Mounjaro, and the company “will continue to evaluate” which other drugs are offered through the service.
Online pharmacies Pharmacy2U and Onescript will support LillyDirect as dispensing partners, it added.
Read more: Retatrutide trials show promise for treating obesity-related conditions
Lilly said the healthcare professionals at the private companies it provides the service to will retain “discretion and ultimate responsibility for all prescribing decisions and for the patient-clinician relationship”.
“Lilly plays no role in any clinical decisions relating to patient care,” it noted.
And it added that LillyDirect aims to “ensure that authentic, Lilly-manufactured medicines are delivered to patients” and help “safeguard against the risk of counterfeit products entering the supply chain”.
Read more: Lilly GLP-1 pill can keep weight off after stopping jabs, study finds
It comes after Lilly’s investigational weight loss drug retatrutide showed “meaningful improvements” across common obesity-related conditions in phase 3 trials earlier this month.
And it follows the drugmaker’s oral GLP-1 treatment Foundayo receiving US regulatory approval in April.
